A third dose of a COVID-19 vaccine boosts the body's immune response, a Texas A&M expert says, giving added protection against Omicron and other variants.
A Texas A&M epidemiologist says the new variant carries concerning mutations, but when it comes to infectiousness and severity, only time will tell.
A discovery by researchers at the Texas A&M College of Medicine could lead to new therapies to prevent the virus from proliferating in the human body.
By sampling dogs and cats whose owners have tested positive in Brazos County, the team is working to understand how pets living in ‘high-risk’ households may be impacted by SARS-CoV-2.
A Texas A&M education expert explains how parents can decide whether to send their kids back to school amid the COVID-19 pandemic.
The document from the Scowcroft Institute of International Affairs at Texas A&M covers vaccine dissemination, technology, research and more.
FUJIFILM Diosynth Biotechnologies, a Texas A&M University System subcontractor, will mass produce vaccines as part of an agreement between the federal government and the Center for Innovation in Advanced Development and Manufacturing.
Positive tests in a household necessitate extra protection for pets, Texas A&M experts say.
Clinical assistant professor Karl Woodmansey oversees a team of medics at several El Paso testing sites.
Provost Fierke: ‘Taking all possible measures to restore on-campus and in-person research and teaching.’
Texas A&M health public health researchers say Florida's COVID-19 response stands out for both its absence of statewide policies and the unique challenges the state faces.
Preventing the virus from binding to cells could prevent future infections.
Positive cases, hospitalizations and deaths are on the rise. Texas A&M infectious disease experts discuss the direction of the pandemic.